News Release

Myriad Genetics Announces Third Quarter Fiscal 2008 Financial Results Conference Call

Myriad Genetics Announces Third Quarter Fiscal 2008 Financial Results Conference CallSALT LAKE CITY, UT, Apr 23, 2008 (MARKET WIRE via COMTEX News Network) -- Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc. 
DATE: May 6, 2008
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (800) 926-4420
INTERNATIONAL DIAL-IN: (212) 231-2905
RESERVATION NO.: 21381718
(Please dial in approximately 10 minutes before the call is scheduled to
begin)

A press release will be issued at 6:30 am ET.

Replay of the call will be available from two hours after the call for seven days. It can be accessed by dialing (800) 633-8284 from the United States, or +1 402 977 9140 internationally, and entering the reservation number.

Live audio webcast of the call will be available at: www.myriad.com 

Contact:
Suzanne Barton
Myriad Genetics
(801) 584-1138

SOURCE: Myriad Genetics, Inc.